MEBO Gastrointestinal Capsule
- Company Name:MEBO International Group
- Membership:Free Member
- Member Since:2008. 12.31
- Country/Region:China
- City:Beijing
- Contact:Michael Wu
- Related Keywords:GI Track, gastrointestines, refreshing, chronic ulcers
Contact us
MEBO International Group
[China]
The origin of human life is gastrointestinal organ, and the origin of gastrointestinal organ is the gastrointestinal mucosa, and the origin of gastrointestinal mucosa is the function of mucosa villus, the origin of mucosa villus is the enteraden stem cells, and the origin of enteraden stem cell is ensuring the environmental condition and materials needed by regeneration. MEBO Gastrointestinal Capsule adjusts the living environment of gastrointestinal cells to make them live in an optimal environment to obtain balanced nutrition. The in situ regenerated enteraden stem cells replace the damaged cells to recover the normal cell metabolism and prevent gastrointestinal damage, which is the green healthy concept of MEBO Gastrointestinal Capsule.
MEBO Gastrointestinal Capsule supplies biotic protection material (with US patent No. of US5817322), which will help establish three-dimentional regenerative space on the damaged gastric mucosa to prevent all kinds of stimulation from food or gastric acid and to assure the successfule achievement of mucosa regeneration. At the same time, MEBO Gastrointestinal Capsule suppies Gastrointestinal Component (GIC, with US patent No. of US6685971 B2), the necessary nutrients for mucosa regeneration. With the help of GIC, the Potential Regenerative Cells(PRCs) in the gastrointestinal mucosa can regenerate the damaged mucosa or replace the aged and nonfunctioning mucosa with a anagen cycle of 30 days.
Second: Product characteristics
1. It’s developed according to the physiological character of gastrointestine with rich and balanced nutrition, which can adequately satisfy the requirements of gastrointestinal mucosa in situ regeneration.
2. The critical technique is based on the world-leading human tissue organ regenerative medicine theory. It contains biotic protection material and mucosa regenerative material, which have obtaind American patents. This product can protect, regenerate and nourish gastrointestinal mucosa, prevent irritation and damage to gastrointestinal mucosa from alcohol, medicine, spicy food and major operation.
3. The existence of small wax crystal by beeswax can clear the residual food in the small intestine to relieve the gastrointestinal function disorder. Meanwhile, the constant slow-release of nutrient contained in the small wax crystal can improve the gastrointestinal absorptivity of nutrient.
4. Adjust lipid metabolism, loose bowel to relieve constipation, improve gastrointestine function to keep human body healthy.
5. Made of natural food. It can be administered in short or long time.
6. No toxic side effect, doesn’t contain any stimulant.
Third: Applicable persons
1. Persons with long-term gastrointestinal mucosa damage without repairing: there are kinds of mucosa damage under the observation of gastroscope, including kinds of chronic gastroenteritis and stomach intestine ulcer.
2. Persons drink often and take part in social appointment:often drink kinds of whoopee water, especially with the amount larger than 200 ml distillate spirit.
3. White-collar female:Because of physiological feature and work character, gastrointestinal dysfunction can occur easily in combination with kinds of autonomic nerve chaotic that related to the irriation of the nerve ending of the microlesion within gastrointestine.
4. For fat persons on the process of diet:The intestinal mucosa will shrink back with different degree because of short of the irritant of enough food. Long-term diet will cause digesting and absorbing functional disturbance easily.
5. For patients after taking chemicals and radiotherapy:Many chemical especially anti-inflammatory medicine; after chemo, gastrointestinal mucosa ulcer complication occur easily and hard to heal.
6. For the aged:The amount of mucous secretion on the gastrointestinal mucosa decreased and the defense function decreased too. So the resistance to all kinds of irritation is weak and also the repair ability. For this kind of person, gastrointestinal mucosa protection and also nutrient absorption rate should be strengthened.
Fourth: Administration and Dosage
For oral administration. A dose of 3-5 pills per taking, twice daily is for adults and 1-3 pills for children, either before or after meals. Immediate administer whenever feel gastrointestinal upset.
Fifth: Clinical efficacy
In the control group, Lizhu Dele which is a medicine for treating gastrosia is used. While in the treatment group, only MEBO Gastrointestinal Capsule, which is a healthcare food is used.
The Clinical Efficacy of MEBO Gastrointestinal Capsule to 60 Cases of Disease of Upper Digestive Tract
July-December, 2005
|
Cure Rate |
Effective Power |
Treatment Group(GIC) |
93.3% |
100% |
Control Group(Lizhu Dele) |
90% |
100% |
|
Male |
Female |
Total |
Treatment Group (GIC) |
21 |
9 |
30 |
Control Group (Lizhu Dele) |
20 |
10 |
30 |
|
Gastrohelcoma |
Erosive Gastritis |
Duodenobulbar Ulcer |
Esophagitis |
Total |
Treatment Group (GIC) |
4 |
13 |
12 |
1 |
30 |
Control Group(Lizhu Dele) |
5 |
10 |
13 |
2 |
30 |
Sixth: Cases
Case 1
A 78-year-old female patient, with multiple chronic superficial gastritis in stomach.
Before treatment
A Corpus gastricum B Angle of the stomach C Fundus gastricus
D Fundus gastricus E Sinus ventriculi F Cardia ventriculi
After treatment
A Bulbar zone B Angle of the stomach C Fundus gastricus
D Corpus gastricum E Sinus ventriculi F Cardia ventriculi
Case 2
A 59-year-old male patient, with chronic superficial gastritis.
Before treatment
A Bulbar zone B Angle of the stomach C Fundus gastricus
D Corpus gastricum E Sinus ventriculi F Cardia ventriculi
After treatment
A Bulbar zone B Angle of the stomach C Fundus gastricus
D Corpus gastricum E Sinus ventriculi F Cardia ventriculi
Case 3
A 54-year-old female patient, with non-atrophic gastritis
Before treatment
After treatment
Case 4
A 48-year-old male patient with non-atrophic gastritis
Before treatment
After treatment
Other products from this supplier
Browse: Manufacturer Directory Countries China India Korea Premium Suppliers Community Site Map
About EC21 Contact Us Terms & Conditions Report Item Online Trading Risks Product Listing Policy
中文 繁體 한국어 日本語 Español Русский Français Deutsch
Copyright (c)1997-2024 EC21 Inc. All Rights Reserved. EC21 in KoreanChinese
Business Registry Number: 120-86-03931